Or manufacturers can grant royaltyfree licenses to counterparts in developing countries to make such products. 마지막 두 가지 옵션의 목적은 독감 백신 제조 역량을 보다 광범위하게 확산하는 것입니다. Now its almost entirely based in developed nations.